Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation.
Golling
M
M
Department of Surgery, University of Heidelberg, Germany.
Lehmann
T
T
Senninger
N
N
Herfarth
C
C
Otto
G
G
D000704:Analysis of Variance; D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism*; D002096:C-Peptide / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D005951:Glucose Tolerance Test; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D012189:Retrospective Studies; D016559:Tacrolimus / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D013997:Time Factors
D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D007166:Immunosuppressive Agents; D007328:Insulin; D016559:Tacrolimus